Early Cytomegalovirus Reactivation Leaves a Specific and Dynamic Imprint on the Reconstituting T Cell Compartment Long-Term after Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 5, 2014, Pages 655-661

  Lugthart, Gertjan ^a   van Ostaijen ten Dam, Monique M ^a   Jol van der Zijde, Cornelia M ^a   van Holten, Tessa C ^a   Kester, Michel G D ^a   Heemskerk, Mirjam H M ^a   Bredius, Robbert G M ^a   van Tol, Maarten J D ^a   Lankester, Arjan C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cytomegalovirus; Immune reconstitution; Pediatric hematopoietic stem cell transplantation; T cell differentiation

Indexed keywords

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL EXPANSION; CHILD; CYTOMEGALOVIRUS INFECTION; EFFECTOR CELL; END STAGE EFFECTOR T CELL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOLOGICAL MEMORY; INFANT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; SCHOOL CHILD; T CELL RECONSTITUTION; T LYMPHOCYTE; VIRUS REACTIVATION; ADOLESCENT; ALLOTRANSPLANTATION; COMPLICATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EPSTEIN BARR VIRUS; EPSTEIN-BARR VIRUS INFECTIONS; HEMATOLOGIC DISEASES; IMMUNOLOGY; LONGITUDINAL STUDY; PATHOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; TIME; VIROLOGY; VIRUS ACTIVATION;

ADOLESCENT; ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOLOGIC MEMORY; INFANT; LONGITUDINAL STUDIES; LYMPHOCYTE COUNT; MALE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; VIRUS ACTIVATION;

EID: 84897962239     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.01.018     Document Type: Article

References (43)

1. Sinclair J. Human cytomegalovirus: Latency and reactivation in the myeloid lineage. JClin Virol 2008, 41:180-185.
2. Hebart H., Einsele H. Clinical aspects of CMV infection after stem cell transplantation. Hum Immunol 2004, 65:432-436.
3. Boeckh M., Nichols W.G. The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy. Blood 2004, 103:2003-2008.
4. Cwynarski K., Ainsworth J., Cobbold M., et al. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood 2001, 97:1232-1240.
5. Li C.R., Greenberg P.D., Gilbert M.J., et al. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 1994, 83:1971-1979.
6. Barron M.A., Gao D., Springer K.L., et al. Relationship of reconstituted adaptive and innate cytomegalovirus (CMV)-specific immune responses with CMV viremia in hematopoietic stem cell transplant recipients. Clin Infect Dis 2009, 49:1777-1783.
7. Williams K.M., Hakim F.T., Gress R.E. Tcell immune reconstitution following lymphodepletion. Semin Immunol 2007, 19:318-330.
8. Tchao N.K., Turka L.A. Lymphodepletion and homeostatic proliferation: implications for transplantation. Am J Transplant 2012, 12:1079-1090.
9. Appay V., van Lier R.A., Sallusto F., et al. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 2008, 73:975-983.
10. Romero P., Zippelius A., Kurth I., et al. Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. JImmunol 2007, 178:4112-4119.
11. Appay V., Dunbar P.R., Callan M., et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002, 8:379-385.
12. Gamadia L.E., Rentenaar R.J., Baars P.A., et al. Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers. Blood 2001, 98:754-761.
13. Looney R.J., Falsey A., Campbell D., et al. Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol 1999, 90:213-219.
14. Marchant A., Appay V., Van Der Sande M., et al. Mature CD8(+) T lymphocyte response to viral infection during fetal life. JClin Invest 2003, 111:1747-1755.
15. Kuijpers T.W., Vossen M.T., Gent M.R., et al. Frequencies of circulating cytolytic, CD45RA+CD27-, CD8+ T lymphocytes depend on infection with CMV. JImmunol 2003, 170:4342-4348.
16. Miles D.J., van der Sande M., Jeffries D., et al. Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation. JVirol 2007, 81:5766-5776.
17. Miles D.J., van der Sande M., Jeffries D., et al. Maintenance of large subpopulations of differentiated CD8 T-cells two years after cytomegalovirus infection in Gambian infants. PLoS One 2008, 3:e2905.
18. van de Berg P.J., van S.A., ten Berge I.J., et al. Afingerprint left by cytomegalovirus infection in the human T cell compartment. JClin Virol 2008, 41:213-217.
19. Cantisan S., Torre-Cisneros J., Lara R., et al. Age-dependent association between low frequency of CD27/CD28 expression on pp65 CD8+ T cells and cytomegalovirus replication after transplantation. Clin Vaccine Immunol 2009, 16:1429-1438.
20. Peggs K.S., Verfuerth S., Pizzey A., et al. Reconstitution of T-cell repertoire after autologous stem cell transplantation: influence of CD34 selection and cytomegalovirus infection. Biol Blood Marrow Transplant 2003, 9:198-205.
21. Luo X.H., Huang X.J., Li D., et al. Immune reconstitution to cytomegalovirus following partially matched-related donor transplantation: impact of invivo T-cell depletion and granulocyte colony-stimulating factor-primed peripheral blood/bone marrow mixed grafts. Transpl Infect Dis 2013, 15:22-33.
22. Wursch A.M., Gratama J.W., Middeldorp J.M., et al. The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation. Clin Exp Immunol 1985, 62:278-287.
23. Niesters H.G., van Esser J., Fries E., et al. Development of a real-time quantitative assay for detection of Epstein-Barr virus. JClin Microbiol 2000, 38:712-715.
24. Claas E.C., Schilham M.W., de Brouwer C.S., et al. Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients. JClin Microbiol 2005, 43:1738-1744.
25. Kalpoe J.S., Kroes A.C., de Jong M.D., et al. Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection. JClin Microbiol 2004, 42:1498-1504.
26. Boeckh M., Ljungman P. How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood 2009, 113:5711-5719.
27. Meijer E., Cornelissen J.J. Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients. Curr Opin Hematol 2008, 15:576-585.
28. van Tol M.J., Claas E.C., Heemskerk B., et al. Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity. Bone Marrow Transplant 2005, 35(Suppl 1):S73-S76.
29. Shaulov A., Murali-Krishna K. CD8 T cell expansion and memory differentiation are facilitated by simultaneous and sustained exposure to antigenic and inflammatory milieu. JImmunol 2008, 180:1131-1138.
30. Gamadia L.E., van Leeuwen E.M., Remmerswaal E.B., et al. The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines. JImmunol 2004, 172:6107-6114.
31. van Leeuwen E.M., Koning J.J., Remmerswaal E.B., et al. Differential usage of cellular niches by cytomegalovirus versus EBV- and influenza virus-specific CD8+ T cells. JImmunol 2006, 177:4998-5005.
32. Wherry E.J. Tcell exhaustion. Nat Immunol 2011, 12:492-499.
33. Cicin-Sain L., Sylwester A.W., Hagen S.I., et al. Cytomegalovirus-specific T cell immunity is maintained in immunosenescent rhesus macaques. JImmunol 2011, 187:1722-1732.
34. Day C.L., Kaufmann D.E., Kiepiela P., et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006, 443:350-354.
35. Hertoghs K.M., Moerland P.D., van S.A., et al. Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation. JClin Invest 2010, 120:4077-4090.
36. Matloubian M., Concepcion R.J., Ahmed R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. JVirol 1994, 68:8056-8063.
37. Walter E.A., Greenberg P.D., Gilbert M.J., et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. NEngl J Med 1995, 333:1038-1044.
38. van Leeuwen E.M., Remmerswaal E.B., Heemskerk M.H., et al. Strong selection of virus-specific cytotoxic CD4+ T-cell clones during primary human cytomegalovirus infection. Blood 2006, 108:3121-3127.
39. Dechanet J., Merville P., Lim A., et al. Implication of gammadelta T cells in the human immune response to cytomegalovirus. JClin Invest 1999, 103:1437-1449.
40. Lafarge X., Merville P., Cazin M.C., et al. Cytomegalovirus infection in transplant recipients resolves when circulating gammadelta T lymphocytes expand, suggesting a protective antiviral role. JInfect Dis 2001, 184:533-541.
41. Remmerswaal E.B., Havenith S.H., Idu M.M., et al. Human virus-specific effector-type T cells accumulate in blood but not in lymph nodes. Blood 2012, 119:1702-1712.
42. Klarenbeek P.L., Remmerswaal E.B., ten Berge I.J., et al. Deep sequencing of antiviral T-cell responses to HCMV and EBV in humans reveals a stable repertoire that is maintained for many years. PLoS Pathog 2012, 8:e1002889.
43. Elmaagacli A.H., Steckel N.K., Koldehoff M., et al. Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood 2011, 118:1402-1412.